Calamos Advisors LLC Acquires 6,207 Shares of Humana Inc. (NYSE:HUM)

Calamos Advisors LLC raised its holdings in Humana Inc. (NYSE:HUM) by 8.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 76,948 shares of the insurance provider’s stock after purchasing an additional 6,207 shares during the quarter. Calamos Advisors LLC owned approximately 0.06% of Humana worth $35,228,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Rakuten Securities Inc. bought a new position in Humana in the 4th quarter valued at $25,000. Gradient Investments LLC raised its position in Humana by 200.0% in the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 40 shares during the last quarter. Sunbelt Securities Inc. bought a new position in Humana in the 1st quarter valued at $28,000. Householder Group Estate & Retirement Specialist LLC bought a new position in Humana in the 3rd quarter valued at $39,000. Finally, Nvwm LLC raised its position in Humana by 41.0% in the 3rd quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after purchasing an additional 25 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently commented on HUM shares. Mizuho lowered their target price on Humana from $550.00 to $400.00 and set a “buy” rating for the company in a research note on Friday, January 26th. Barclays lowered their target price on Humana from $356.00 to $310.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 2nd. Cantor Fitzgerald reissued a “neutral” rating and issued a $391.00 target price on shares of Humana in a research note on Wednesday, April 10th. Argus cut Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, March 13th. Finally, Oppenheimer reissued an “outperform” rating and issued a $630.00 target price on shares of Humana in a research note on Wednesday, January 17th. Eleven research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, Humana currently has an average rating of “Hold” and a consensus price target of $465.42.

Humana Stock Up 0.4 %

Shares of HUM traded up $1.37 during mid-day trading on Thursday, hitting $324.83. 1,475,316 shares of the company’s stock were exchanged, compared to its average volume of 2,008,112. The company has a market cap of $39.19 billion, a PE ratio of 16.47, a P/E/G ratio of 1.86 and a beta of 0.45. Humana Inc. has a 52 week low of $299.23 and a 52 week high of $541.21. The company has a 50-day simple moving average of $344.41 and a 200 day simple moving average of $425.71. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.59 and a quick ratio of 1.59.

Humana (NYSE:HUM) last issued its quarterly earnings results on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share for the quarter, missing the consensus estimate of $0.76 by ($0.87). The business had revenue of $26.46 billion for the quarter, compared to the consensus estimate of $25.47 billion. Humana had a return on equity of 19.44% and a net margin of 2.34%. Humana’s revenue was up 17.9% compared to the same quarter last year. During the same period in the prior year, the business earned $1.62 earnings per share. On average, research analysts forecast that Humana Inc. will post 16.06 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.09%. Humana’s payout ratio is presently 17.86%.

Insider Activity

In related news, Director Jorge S. Mesquita acquired 545 shares of the business’s stock in a transaction dated Tuesday, February 20th. The stock was bought at an average price of $367.09 per share, with a total value of $200,064.05. Following the acquisition, the director now owns 2,578 shares in the company, valued at approximately $946,358.02. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.32% of the stock is currently owned by insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.